We are not too slow. Original ambitions haven’t been met, but so what, they are trying to achieve 18-24 months of effort. They’re working exceptionally hard and it looks like results will be incredible. Let’s praise it rather than knock it.
I assume the implication of the other thread is the usual nonsense that we’ll be late to the party... absolute nonsense. Our tests will be needed now for mass screening and will continue to be needed in key areas for many months, possibly getting in to years. I recommended bookmarking this, please do:
Let’s stick to facts. Covid is still rampant. A couple of additional weeks to optimise and ensure the LFD is the absolute best in class & capable of mass screening across the globe is not of any concern whatsoever. Even if that chart was flat or falling, there is still a desperate need for our test to stop a resurgence. Don’t forget the possibility of a second wave. The vast majority of the global population haven’t had it yet and we don’t truly know about any form of immunity.
RE: Avacta Point of Care Announcement?02 Jul 2020 22:37
Yes, slide 12... It’s the most amazing bar chart I’ve ever seen. When I first saw this the only thing I could say, and I did, out loud and I’m not one for that kind of thing, was... wow. It’s incredible and I dearly hope the trials go well and it becomes a reality.
Cross ramp? I’m not a fan of that personally *cough*GDR*cough*, I prefer each board to stay focused *cough*great global product, low market cap*cough*. I think it’s best if we do our own research independently. *cough*awaiting approvals and sales*cough*
I must get that cough checked out with an Awacta test...
Please don’t say ‘a few weeks’, he definitely said a couple of weeks, so we’re getting closer! Your comment was fair, we’ve clearly had the share price messed about a bit, but we all know what’s coming so it’s just a case of holding and adding if you can. Sir Al thinks this is a fair price not taking in to account Covid, so there’s very little downside risk.